Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,593 High Cholesterol
clinical trials

Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Torrance, CA
Click here to add this to my saved trials
Severe Familial Hypercholesterolemia Clinical Trial
Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders
Status: Enrolling, Phase II, III
Updated: 3/11/2015
mi
from
New York, NY
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Augusta, GA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Aurora, CO
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Austin, TX
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Buffalo, NY
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Glendale, AZ
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Jackson, TN
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Oxnard, CA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Rapid City, SD
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Richmond, VA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Salisbury, MD
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Savannah, GA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Seattle, WA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Slidell, LA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Springfield, OH
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Waterloo, IA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status: Enrolling, Phase III
Updated: 7/29/2015
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Homozygous Familial Hypercholesterolemia Clinical Trial
Study of REGN1500 in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
Status: Enrolling, Phase II
Updated: 9/28/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Elkridge, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Lincoln, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Status: Enrolling, Phase III
Updated: 2/2/2016
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cary, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cottonwood, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Covington, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Hillsboro, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Orem, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Richmond, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Shreveport, LA
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Atlantis, FL
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Innsbruck,
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Jamaica, NY
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Maumee, OH
Click here to add this to my saved trials
Hypercholesterolaemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Roswell, GA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Status: Enrolling, Phase IV
Updated: 3/16/2016
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Anaheim, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Carrollton, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Northridge, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Port Orange, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Springfield, IL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Status: Enrolling, Phase III
Updated: 4/29/2015
mi
from
Brockton, MA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Covington, LA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Duluth, MN
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Hershey, PA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Huntsville, AL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Long Beach, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Missoula, MT
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Omaha, NE
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Petoskey, MI
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Safety Harbor, FL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Status: Enrolling, Phase III
Updated: 11/6/2014
mi
from
Tulsa, OK
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling, Phase III
Updated: 2/24/2014
mi
from
Boston, MA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
A Study of Alirocumab (REGN727/SAR236553) in Patients With ADH and GOFm of the PCSK9 Gene or LOFm of the apoB Gene
Status: Enrolling, Phase II
Updated: 11/21/2013
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Denver, CO
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial
Status: Enrolling
Updated: 6/26/2013
mi
from
Kalispell, MT
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Austin, TX
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Columbia, MD
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Duncansville, PA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Encinitas, CA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Hillsboro, OR
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Jackson, TN
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Rapid City, SD
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Savannah, GA
Click here to add this to my saved trials
Hyperlipidemia and Mixed Dyslipidemia Clinical Trial
Open Label Study of Long Term Evaluation Against LDL-C Trial-2
Status: Enrolling, Phase III
Updated: 7/22/2015
mi
from
Tustin, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
Status: Enrolling, Phase III
Updated: 4/16/2014
mi
from
Durham, NC
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypercholesterolemia Clinical Trial
Open Label Study of Long Term Safety Evaluation of Alirocumab
Status: Enrolling, Phase III
Updated: 8/5/2015
mi
from
Marion, OH
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16